Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Abingworth Raises $582 Million for New Clinical Co-development Fund – ACCD 2
Abingworth, a leading international life sciences investment group, today announced the final closing of its […]
Collective Health Secures $280 Million to Accelerate the Digital Transformation of Healthcare
Health technology company Collective Health today announced it secured $280 million in funding in a […]
Vida Health Raises $110m in Series D Round Led by General Atlantic, Centene, and Axa Venture Partners
Virtual chronic care platform Vida Health announced today that it raised $110M in its Series […]
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
Alebund Pharmaceuticals (“Alebund” or the “Company”), a biopharmaceutical company dedicated to developing innovative therapies for […]
Cumulus Neuroscience Announces £6 million Funding Round
Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led […]
MD Ally Announces $3.5M Seed Round to Connect 9-1-1 and First Responders to Telehealth, Mental Health and Social Services
MD Ally, a 911-powered telehealth company, today announced a $3.5M seed round to expand the […]
Caresyntax Raises $100 Million
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and […]
Novo Holdings Participates in US$ 80 Million Series C Investment in Indonesia's Largest Health-tech Platform Halodoc
Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, […]
Seed Health Closes $40 Million in Series A Financing
Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced […]
OS Therapies Completes $6 Million Series A Funding Round
OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more